The observation that PAK4 KO tumors require the addition of anti-PD-1 to decrease tumor growth, highlights the importance of overcoming adaptive immune resistance mechanisms and blocking the PD-1/PD-L1 interaction. Here, CD274 is linked to neoplasm.